Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 7 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Sol-Gel Technologies Ltd. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 14 | 15 | +1 |
| Shares | 5.70M | 8.06M | +2.36M (+41.5%) |
| Value | $26.0M | $31.3M | +$5.29M (+20.4%) |
New holders (2)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,408,000 | $9.34M | 0.22% |
| Allworth Financial LP | 2,507 | $9.73K | 0.00% |
Sold out (1)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| UBS Group AG | 2,983 | $13.6K |